CYP19A1 and breast carcinoma: Findings from other oncological models highlight excess adiposity-associated impact in methylation markers known to associate with potential effect in the cancer microenvironment (e.g., aromatase, prostaglandin E2 receptor in breast cancer) [34, 35].